Non-small cell lung cancer

Showing 9 of 0 results

• A retrospective real-world study of first-line PD-(L)1 inhibitor use in patients with metastatic non-small cell lung cancer (mNSCLC)

  ASCO Annual Conference

  • Publication summary
  • Publications
  • Non-small cell lung cancer
• Real-world surgical and treatment patterns after neoadjuvant checkpoint inhibition in US patients with stage II/III non-small cell lung cancer

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Treatment patterns
  • Non-small cell lung cancer
• Concordance of response-based clinical trial and machine learning–generated real-world end points

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Machine learning
  • Non-small cell lung cancer
• Using regression discontinuity in time design for real-world comparative effectiveness: A case study for the second-line use of pembrolizumab in advanced non-small cell lung cancer

  ISPOR 2025

  • Publication summary
  • Publications
  • Comparative effectiveness
  • Non-small cell lung cancer
• Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLC

  ISPOR

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • Non-small cell lung cancer
• Evaluating transportability of overall survival estimates from US to UK populations receiving first-line treatment for advanced non-small cell lung cancer: a retrospective cohort study

  BMJ Open

  • Publication summary
  • Publications
  • Non-small cell lung cancer
  • HTA and market access
• Real-world clinico-genomic evidence can fill knowledge gaps and identify unmet needs for patients with lung cancer
  • Real-world evidence
  • Case study
  • Event recap
  • Article
  • Non-small cell lung cancer
• Evaluation of real-world tumor response derived from electronic health record data sources: A feasibility analysis in mNSCLC patients treated with chemotherapy

  JCO Clinical Cancer Informatics

  • Real-world evidence
  • Non-small cell lung cancer
  • Regulatory
• Racial/ethnic differences in real-world adverse events and survival among patients receiving immunotherapy for advanced NSCLC

  World Conference of Lung Cancer

  • Real-world evidence
  • Publication summary
  • Publications
  • Non-small cell lung cancer